Emerging Company Profile
ONK’s CAR NK cells hit the TRAIL
Emerging Company Profile: Ireland’s ONK Therapeutics soups up CAR NK cells with TRAIL variants
With its TRAIL variants, Ireland’s ONK Therapeutics aims to increase the potency of and reduce resistance to its CAR NK cells.
Jan 23, 2021 | 12:02 AM GMT
ONK thinks its engineered TRAIL variants will make CAR NK